prostate cancer with particular inherited or acquired abnormal genes identified as homologous recombination repair service (HRR genes). LYNPARZA is utilised if the cancer has unfold to other areas of the body (metastatic), and no longer responds to some medical or surgical therapy that lowers testosterone, and it has progressed following therapy wi